Last reviewed · How we verify

NCT05013411

Rethinking Observations in Mental Health

Completed Last updated 20 March 2025
What this trial tests

trial testing Qualitative study in Vital Signs in 7 participants. Completed in 1 February 2022.

Timeline
15 October 2021
Primary endpoint
1 February 2022
1 February 2022

Quick facts

Lead sponsorOxehealth Limited
StatusCompleted
Study typeOBSERVATIONAL
Enrollment7
Start date15 October 2021
Primary completion1 February 2022
Estimated completion1 February 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Oxehealth Limited

Who can join

Eligibility, any sex, with Vital Signs. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To gain healthcare workers' perception of the current observations practices used in patient care and explore the benefits of using technology to enhance observations in inpatient mental health setting in the United Kingdom.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Qualitative study

Trials testing the same drug.

Other recruiting trials for Vital Signs

Currently open trials in the same condition.

Other Oxehealth Limited trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05013411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing